Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimer's disease biomarkers for hypothetical disease-modifying treatment decision in mild cognitive impairment
Handels, Ron L.H., Joore, Manuela A., Tran-Duy, An, Wimo, Anders, Wolfs, Claire A.G., Verhey, Frans R.J., Severens, Johan L.Volume:
11
Language:
english
Journal:
Alzheimer's & Dementia
DOI:
10.1016/j.jalz.2015.02.009
Date:
August, 2015
File:
PDF, 1.22 MB
english, 2015